Synthesis and evaluation of antioxidant and trypanocidal properties of a selected series of coumarin derivatives

Papers of special note have been highlighted as: ▪ of interest ▪▪ of considerable interest

References

• 1  Borges F, Roleira F, Milhazes N, Santana L, Uriarte E. Simple coumarins and analogs in medicinal chemistry: occurrence, synthesis and biological activity. Curr. Med. Chem.12,887–916 (2005).▪▪ Very interesting review of coumarins.
  Medline CASGoogle Scholar
• 2  Borges F, Roleira F, Milhazes N, Uriarte E, Santana L. Simple coumarins: privileged scaffolds in medicinal chemistry. Front. Med. Chem.4,23–85 (2009).▪▪ Very interesting review of coumarins.
  Google Scholar
• 3  Riveiro ME, De Kimpe N, Moglioni A et al. Coumarins: old compounds with novel promising therapeutic perspectives. Curr. Med. Chem.17,1325–1338 (2010).▪▪ Interesting review of promising therapeutic applications of coumarins.
  Medline CASGoogle Scholar
• 4  Zhao H, Donnelly AC, Kusuma BR et al. Engineering an antibiotic to fight cancer: optimization of the novobiocin scaffold to produce anti-proliferative agents. J. Med. Chem.54,3839–3853 (2011).
  Medline CASGoogle Scholar
• 5  Vilar S, Quezada E, Santana L et al. Design, synthesis, and vasorelaxant and platelet antiaggregatory activities of coumarin-resveratrol hybrids. Bioorg. Med. Chem. Lett.16,257–261 (2006).
  Medline CASGoogle Scholar
• 6  Kostova I, Bhatia S, Grigorov P et al. Coumarins as antioxidants. Curr. Med. Chem.18,3929–3951 (2011).▪ Interesting review of the coumarin scaffold as antioxidant moiety.
  Medline CASGoogle Scholar
• 7  Ostrov DA, Hernández-Prada JA, Corsino PE, Finton KA, Le N, Rowe TC. Discovery of novel DNA gyrase inhibitors by high-throughput virtual screening. Antimicrob. Agents Chemother.51,3688–3698 (2007).
  Medline CASGoogle Scholar
• 8  Hwu JR, Lin S-Y, Tsay S-C, De Clercq E, Leyssen P, Neyts J. Coumarin-purine ribofuranoside conjugates as new agents against hepatitis C virus. J. Med. Chem.54,2114–2126 (2011).
  Medline CASGoogle Scholar
• 9  Kostova I. Coumarins as inhibitors of HIV reverse transcriptase. Curr. HIV Res.4,347–363 (2006).
  Medline CASGoogle Scholar
• 10  Stefanachi A, Favia AD, Nicolotti O, Leonetti F, Hartmann RW, Carotti A. Design, synthesis, and biological evaluation of imidazolyl derivatives of 4,7-disubstituted coumarins as aromatase inhibitors selective over 17-α-hydroxylase/C17–20 lyase. J. Med. Chem.54,1613–1625 (2011).
  Medline CASGoogle Scholar
• 11  Chilin A, Battistutta R, Bortolato A et al. Coumarin as attractive casein kinase 2 (CK2) inhibitor scaffold: an integrate approach to elucidate the putative binding motif and explain structure-activity relationships. J. Med. Chem.51,752–759 (2008).
  Medline CASGoogle Scholar
• 12  Timonen JM, Nieminen RM, Sareila O, Vainiotalo P, Moilanen E, Aulaskari PH. Synthesis and anti-inflammatory effects of a series of novel 7-hydroxycoumarin derivatives. Eur. J. Med. Chem.46,3845–3850 (2011).
  Medline CASGoogle Scholar
• 13  Soto-Ortega DD, Murphy BP, Gonzalez-Velasquez FJ et al. Inhibition of amyloid-β aggregation by coumarin analogs can be manipulated by functionalization of the aromatic center. Bioorg. Med. Chem.19,2596–2602 (2011).
  Medline CASGoogle Scholar
• 14  Matos MJ, Vazquez-Rodriguez S, Santana L et al. Looking for new targets: simple coumarins as antibacterial agents. Med. Chem.8,1140–1145 (2012).
  Medline CASGoogle Scholar
• 15  Matos MJ, Santana L, Uriarte E et al. Tyrosine-like condensed derivatives as tyrosinase inhibitors. J. Pharm. Pharmacol.64,742–746 (2012).
  Medline CASGoogle Scholar
• 16  Anand P, Singh B, Singh N. A review on coumarins as acetylcholinesterase inhibitors for Alzheimer’s disease. Bioorg. Med. Chem.20,1175–1180 (2012).
  Medline CASGoogle Scholar
• 17  Matos MJ, Viña D, Picciau C, Orallo F, Santana L, Uriarte E. Synthesis and evaluation of 6-methyl-3-phenylcoumarins as potent and selective MAO-B inhibitors. Bioorg. Med. Chem. Lett.19,5053–5055 (2009).
  Medline CASGoogle Scholar
• 18  Matos MJ, Viña D, Quezada E et al. A new series of 3-phenylcoumarins as potent and selective MAO-B inhibitors. Bioorg. Med. Chem. Lett.19,3268–3270 (2009).
  Medline CASGoogle Scholar
• 19  Serra S, Ferino G, Matos MJ et al. Hydroxycoumarins as selective MAO-B inhibitors. Bioorg. Med. Chem. Lett.22,258–261 (2012).
  Medline CASGoogle Scholar
• 20  Viña D, Matos MJ, Yáñez M, Santana L, Uriarte E. 3-Substituted coumarins as dual inhibitors of AChE and MAO for the treatment of Alzheimer´s disease. Med. Chem. Commun.3,213–218 (2012).
  CASGoogle Scholar
• 21  Matos MJ, Terán C, Pérez-Castillo Y, Uriarte E, Santana L, Viña D. Synthesis and study of a series of 3-arylcoumarins as potent and selective monoamine oxidase B inhibitors. J. Med. Chem.54,7127–7137 (2011).
  Medline CASGoogle Scholar
• 22  Matos MJ, Vázquez-Rodriguez S, Uriarte E, Santana L, Viña D. MAO inhibitory activity modulation: 3-phenylcoumarins versus 3-benzoylcoumarins. Bioorg. Med. Chem. Lett.21,4224–4227 (2011).
  Medline CASGoogle Scholar
• 23  Molina E, Sobarzo-Sánchez E, Speck-Planche A et al. Monoamino oxidase A: an interesting pharmacological target for the development of multi-target QSAR. Mini Rev. Med. Chem.12,947–958 (2012).
  Medline CASGoogle Scholar
• 24  Viña D, Matos MJ, Ferino G et al. 8-Substituted-3-arylcoumarins as potent and selective MAO-B inhibitors: synthesis, pharmacological evaluation and docking studies. ChemMedChem7,464–470 (2012).
  Medline CASGoogle Scholar
• 25  Guardado-Yordi E, Pérez-Molina E, Matos MJ, Uriarte E. In: Nutrition, Well-Being and Health. Bouayed J, Bohn T (Eds). InTech, Rijeka, Croatia, 23–48 (2012).
  Google Scholar
• 26  Tyagi YK, Kumar A, Raj HG et al. Synthesis of novel 4-methylcoumarins and evaluation of their antioxidant activity. Eur. J. Med. Chem.40,413–420 (2005).
  Medline CASGoogle Scholar
• 27  Hamdi N, Puerta C, Valerga P. Synthesis, structure and pharmacological investigations of dicoumarols and related compounds. Eur. J. Med. Chem.43,2541–2548 (2008).
  Medline CASGoogle Scholar
• 28  Panteleon V, Kostakis IK, Marakos P, Pouli N, Andreado I. Synthesis and free radical scavenging activity of some new spiropyranocoumarins. Bioorg. Med. Chem. Lett.18,5781–5784 (2008).
  Medline CASGoogle Scholar
• 29  Nordberg J, Arnér ES. Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radical Biol. Med.31,1287–1312 (2001).
  Medline CASGoogle Scholar
• 30  De Oliveira TB, Pedrosa RC, Filho DW. Oxidative stress in chronic cardiopathy associated with Chagas disease. Int. J. Cardiol.116,357–363 (2007).▪ Describes the potential application of antioxidants in Chagas disease.
  MedlineGoogle Scholar
• 31  El-Sayed NM, Myler PJ, Bartholomeu DC et al. The genome sequence of Trypanosoma cruzi, etiologic agent of Chagas disease. Science309,409–415 (2005).
  Medline CASGoogle Scholar
• 32  Schofield CJ, Jannin J, Salvatella R. The future of Chagas disease control. Trends Parasitol.22,583–588 (2006).▪ Interesting concepts about Chagas disease.
  MedlineGoogle Scholar
• 33  Lepesheva GI, Zaitseva NG, Nes WD et al. CYP51 from Trypanosoma cruzi: a phyla-specific residue in the B’ helix defines substrate preferences of sterol 14alpha-demethylase. J. Biol. Chem.281,3577–3585 (2006).
  Medline CASGoogle Scholar
• 34  Bern C, Montgomery SP, Herwaldt BL et al. Evaluation and treatment of Chagas disease in the United States: a systematic review. J. Am. Med. Assoc.298,2171–2181 (2007).
  CASGoogle Scholar
• 35  Castro JA, de Mecca MM, Bartel LC. Toxic side effects of drugs used to treat Chagas’ disease (American trypanosomiasis). Hum. Exp. Toxicol.25,471–479 (2006).
  Medline CASGoogle Scholar
• 36  Gupta S, Wen JJ, Garg NJ. Oxidative stress in Chagas disease. Interdiscip. Perspect. Infect. Dis.190354 (2009).
  MedlineGoogle Scholar
• 37  Bern C. Antitrypanosomal therapy for chronic Chagas’ disease. N. Engl. J. Med.364,2527–2534 (2011).
  Medline CASGoogle Scholar
• 38  Maya JD, Cassels BK, Iturriaga-Vásquez P et al. Mode of action of natural and synthetic drugs against Trypanosoma cruzi and their interaction with the mammalian host. Comp. Biochem. Physiol. A Mol. Integr. Physiol.146,601–620 (2007).▪ Interesting concepts related to Chagas disease.
  MedlineGoogle Scholar
• 39  Urbina JA. Specific chemotherapy of Chagas disease: relevance, current limitations and new approaches. Acta Trop.115,55–68 (2010).
  MedlineGoogle Scholar
• 40  Cerecetto E, Gonzalez M. Chemotherapy of Chagas’ disease: Status and new developments. Curr. Top. Med. Chem.2,1187–1213 (2002).▪ Interesting review of Chagas disease.
  Medline CASGoogle Scholar
• 41  Freitas RF, Prokopczyk IM, Zottis A et al. Discovery of novel Trypanosoma cruzi glyceraldehyde-3-phosphate dehydrogenase inhibitors. Bioorg. Med. Chem.17,2476–2482 (2009).
  Medline CASGoogle Scholar
• 42  Menezes IR, Lopes JCD, Montanari CA et al. 3D QSAR studies on binding affinities of coumarin natural products for glycosomal GAPDH of Trypanosoma cruzi. J. Comput. Aided Mol. Des.17,277–290 (2003).
  Medline CASGoogle Scholar
• 43  Leitão A, Andricopulo, AD, Oliva G et al. Structure–activity relationships of novel inhibitors of glyceraldehyde-3-phosphate dehydrogenase. Bioorg. Med. Chem. Lett.14,2199–2204 (2004).
  Medline CASGoogle Scholar
• 44  Matos MJ, Pérez-Cruz F, Vazquez-Rodriguez S et al. Remarkable antioxidant properties of a series of hydroxy-3-arylcoumarins. Bioorg. Med. Chem.21,3900–3906 (2013).
  Medline CASGoogle Scholar
• 45  Janeiro P, Matos MJ, Santana L, Uriarte E, Oliveira-Brett AM. New hydroxylated 3-arylcoumarins, synthesis and electrochemical study. J. Electroanal. Chem.689,243–251 (2013).
  CASGoogle Scholar
• 46  Perez-Cruz F, Serra S, Delogu G et al. Antitrypanosomal and antioxidant properties of 4-hydroxycoumarins derivatives. Bioorg. Med. Chem. Lett.22,5569–5573 (2012).▪▪ Antitrypanosomal and antioxidant properties of some coumarin derivatives.
  Medline CASGoogle Scholar
• 47  Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods65,55–63 (1983).
  Medline CASGoogle Scholar
• 48  Bisby RH, Brooke R, Navaratnam S. Effect of antioxidant oxidation potential in the oxygen radical absorption capacity (ORAC) assay. Food Chem.108,1002–1007 (2008).
  Medline CASGoogle Scholar
• 49  Vieites M, Otero L, Santos D et al. Platinum(II) metal complexes as potential anti-Trypanosoma cruzi agents. J. Inorg. Biochem.102,1033–1043 (2008).
  Medline CASGoogle Scholar
• 50  Linch FW. 3-Aminocoumarin. J. Chem. Soc.101,1758–1765 (1912).
  CASGoogle Scholar
• 51  Arndt F, Loewe L, Un R, Ayca E. Coumarindiol and coumarin–chromone tautomerism. Chemische Berichte84,319–329 (1951).
  CASGoogle Scholar
• 52  Okumura K. Novobiocin and related compounds. I. Syntheses of 3-acylamino-4-hydroxycoumarin derivatives. Yakugaku Zasshi80,525–532 (1960).
  CASGoogle Scholar
• 53  Merchant JR, Martyres G. Some aminocoumarin derivatives possessing local anesthetic activity. Curr. Science50,410–411 (1981).
  CASGoogle Scholar
• 54  Ou B, Hampsch-Woodill M, Prior RL. Development and validation of an improved oxygen radical absorbance capacity assay using fluorescein as the fluorescent probe. J. Agric. Food Chem.49,4619–4626 (2001).
  Medline CASGoogle Scholar
• 55  Niki E. Assessment of antioxidant capacity in vitro and in vivo. Free Radical Bio. Med.49,503–515 (2010).
  Medline CASGoogle Scholar
• 56  Yoshimura Y, Inomata T, Nakazawa H, Kubo H, Yamaguchi F, Ariga T. Evaluation of free radical scavenging activities of antioxidants with an H(2)O(2)/NaOH/DMSO system by electron spin resonance. J. Agric. Food Chem.47,4653–4656 (1999).
  Medline CASGoogle Scholar
• 57  Muelas-Serrano S, Nogal-Ruiz JJ, Gómez-Barrio A. Setting of a colorimetric method to determine the viability of Trypanosoma cruzi epimastigotes. Parasitol. Res.86,999–1002 (2000).
  Medline CASGoogle Scholar
• 58  Medvidovic-Kosanovic M, Šeruga M, Jakobek L, Novak I. Electrochemical and antioxidant properties of (+)-catechin, quercetin and rutin. Croat. Chem. Acta83,197–207 (2010).
  CASGoogle Scholar
• 59  Hu X-R, He J-B, Wang Y, Zhu Y-W, Tian J-J. Oxidative spectroelectrochemistry of two representative coumarins. Electrochim. Acta56,2919–2925 (2011).
  CASGoogle Scholar
• 60  López-Alarcón C, Lissi E. A novel and simple ORAC methodology based on the interaction of Pyrogallol Red with peroxyl radicals. Free Radical Res.40,979–985 (2006).
  Medline CASGoogle Scholar
• 61  Demoro B, Rossi M, Caruso F et al. Potential mechanism of the anti-trypanosomal activity of organoruthenium complexes with bioactive thiosemicarbazones. Biol. Trace Elem. Res.153(1–3),371-381 (2013).
  Medline CASGoogle Scholar
• 62  Perez-Cruz F, Montecinos R, Villamena FA et al. Protective effect of synthetic hydroxycoumarin derivatives on bovine aortic endothelial cells against oxidative stress induced by 3-morpholinosydnonimine and hydrogen peroxide. Free Radical Biol. Med.53,S115 (2012).
  Google Scholar